Patents by Inventor Leah Price

Leah Price has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250117848
    Abstract: A blockchain-based lending or loan processing platform is provided. The platform comprises: a blockchain onboarding system comprising a smart contract execution environment (CEE). The blockchain onboarding system is configured to: (1) automatically process loan data from a loan origination system (LOS) for virtual execution of one or more loan contracts within the CEE, and the loan data comprises a plurality of loan-related facts; (2) encrypt the loan-related facts to generate a plurality of encrypted facts associated with one or more loan assets; and (3) generate a plurality of hashes for the encrypted facts. The hashes are recorded on a blockchain, and the combinations of each encrypted fact with its corresponding hash are deposited in an encrypted object store (EOS) separate from the blockchain. The platform also comprises a digital asset registration tool (DART) to track substantially in realtime the control, transfers, assignments and/or ownership of controllable electronic records.
    Type: Application
    Filed: September 19, 2024
    Publication date: April 10, 2025
    Inventors: Chris Karlsson, Daniel Wallace, Leah Price, Nicole Beaulieu, Valerie Wagner, David Kneisly
  • Publication number: 20230190790
    Abstract: Provided herein are methods and compositions for the treatment of ALS using chlorite or a pharmaceutical composition comprising sodium chlorite, for a target ALS patient population. Also provided herein are methods for identifying a target ALS patient population likely to be responsive to treatment with chlorite or a pharmaceutical composition comprising sodium chlorite, the methods including identifying ALS patients with elevated plasma C-reactive protein (CRP) levels and/or patients age 40-65, sporadic ALS pathology, or combinations thereof.
    Type: Application
    Filed: February 10, 2023
    Publication date: June 22, 2023
    Inventors: Arasteh Azhir, Michael S. McGrath, Bruce D. Forrest, Leah Price